US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Elicio Therapeutics

2.75

-0.0900-3.17%

Volume:125.94K

Turnover:349.14K

Market Cap:72.28M

PE:-1.27

High:2.87

Open:2.84

Low:2.74

Close:2.84

52wk High:16.00

52wk Low:2.66

Shares:26.28M

Float Shares:19.19M

Volume Ratio:2.20

T/O Rate:0.66%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-2.1721

EPS(LYR):-2.5842

ROE:-774.56%

ROA:-77.88%

PB:9.11

PE(LYR):-1.06

Loading ...

Overview Company News Filings

Elicio Therapeutics Prices $15 Million Direct Offering

MT Newswires Live

Elicio Therapeutics Announces Pricing of $15 Million Registered Direct Offering

THOMSON REUTERS

Elicio Therapeutics Added to Russell 2000® and Russell 3000® Indexes

Elicio Therapeutics Posts Amplify-7p Presentation on Eli-002 7P in Metastatic Mkras Pancreatic Cancer

Analysts Conflicted on These Healthcare Names: Phathom Pharmaceuticals (PHAT) and Elicio Therapeutics (ELTX)

Analysts Have Conflicting Sentiments on These Healthcare Companies: Damora Therapeutics (DMRA), Summit Therapeutics (SMMT) and Elicio Therapeutics (ELTX)

Elicio Therapeutics Coverage Assumed by Ladenburg Thalmann at Buy

Elicio Therapeutics assumed with a Buy at Ladenburg

Top Premarket Decliners

MT Newswires Live

Elicio Reports Complete Responses in 3 Pancreatic Cancer Patients After ELI-002 7P, Nivolumab Treatment

MT Newswires Live

Elicio Therapeutics reports complete responses in pancreatic cancer trial

Elicio Therapeutics plans Phase 1 trial of ELI-002 7P plus anti-PD-1, chemo in metastatic mKRAS pancreatic cancer

Elicio Therapeutics - Complete Responses Observed in Mss/Mmr-P Patients With Historically Checkpoint Inhibitor Response

THOMSON REUTERS

Elicio Therapeutics - Reports 100% Confirmed Complete Responses in Three Patients After Eli-2 7P and Nivolumab

THOMSON REUTERS

Elicio Therapeutics - Two Patients Maintain Complete Responses for at Least Eight Months, One Over 13 Months

THOMSON REUTERS

Elicio Therapeutics - Plans to Initiate Phase 1 Study in Metastatic Pancreatic Ductal Adenocarcinoma

THOMSON REUTERS

Elicio Therapeutics Reports Multiple Complete Responses After Eli-002 7P Treatment and Subsequent Therapy With Checkpoint Inhibition in Metastatic Mkras Pancreatic Cancer

THOMSON REUTERS

SueWallSt opens probe into Elicio Therapeutics officers, directors after 72.53% stock plunge

Elicio Therapeutics Cut to Hold From Buy by Jones Trading

Elicio Therapeutics downgraded to Hold from Buy at JonesResearch

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/stock/ELTX/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ELTX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ELTX\",,,,,undefined,":{"symbol":"ELTX","market":"US","secType":"STK","nameCN":"Elicio Therapeutics","latestPrice":2.75,"timestamp":1788188210213,"preClose":2.84,"halted":0,"volume":125939,"delay":0,"changeRate":-0.03169014084507037,"floatShares":19192300,"shares":26281900,"eps":-2.172087,"marketStatus":"Trading","change":-0.09,"latestTime":"08-31 10:57:31 EDT","open":2.84,"high":2.8699,"low":2.74,"amount":349135.7402973,"amplitude":0.045739,"askPrice":2.76,"askSize":170,"bidPrice":2.75,"bidSize":600,"shortable":3,"etf":0,"ttmEps":-2.172087,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1788206400000},"marketStatusCode":2,"adr":0,"listingDate":1612501200000,"exchange":"NASDAQ","adjPreClose":2.84,"preHourTrading":{"tag":"盘前","latestPrice":2.81,"preClose":2.84,"latestTime":"09:28 EDT","volume":746,"amount":2138.959921,"timestamp":1788182921107,"change":-0.03,"changeRate":-0.010563,"amplitude":0.133803},"postHourTrading":{"tag":"盘后","latestPrice":2.86,"preClose":2.84,"latestTime":"19:34 EDT","volume":961,"amount":2744.423,"timestamp":1787960056390,"change":0.02,"changeRate":0.007042,"amplitude":0.007042},"volumeRatio":2.195562,"impliedVol":2.3392,"impliedVolPercentile":0.8247},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ELTX\",,,,,undefined,":{"symbol":"ELTX","floatShares":19192300,"roa":"-77.88%","roe":"-774.56%","lyrEps":-2.584186,"volumeRatio":2.195562,"shares":26281900,"dividePrice":0,"high":2.8699,"amplitude":0.045739,"preClose":2.84,"low":2.74,"week52Low":2.66,"pbRate":"9.11","week52High":16,"institutionHeld":0,"latestPrice":2.75,"committee":0.558442,"eps":-2.172087,"divideRate":0,"volume":125939,"delay":0,"ttmEps":-2.172087,"open":2.84,"prevYearClose":7.96,"prevWeekClose":2.84,"prevMonthClose":2.8,"prevQuarterClose":3.91,"fiveDayClose":2.98,"twentyDayClose":2.86,"sixtyDayClose":13.93},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ELTX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-13","symbol":"ELTX","fiscalQuarterEnding":"2026/06","expectedEps":-0.53,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1786593600000,"reportTimeType":"post","actualEps":-0.43},{"market":"US","date":"2026-05-11","symbol":"ELTX","fiscalQuarterEnding":"2026/03","expectedEps":-0.49,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1778472000000,"reportTimeType":"post","actualEps":-0.65},{"market":"US","date":"2026-03-12","symbol":"ELTX","fiscalQuarterEnding":"2025/12","expectedEps":-0.47,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1773288000000,"reportTimeType":"post","actualEps":-0.49},{"market":"US","date":"2025-11-13","symbol":"ELTX","fiscalQuarterEnding":"2025/09","expectedEps":-0.62,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1763010000000,"reportTimeType":"post","actualEps":-0.6},{"market":"US","date":"2025-08-07","symbol":"ELTX","fiscalQuarterEnding":"2025/06","expectedEps":-0.69,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1754539200000,"reportTimeType":"post","actualEps":-0.66}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ELTX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ELTX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.25,"buy":0.5,"hold":0.25,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5,"analysts":4,"updateTime":1781841600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ELTX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ELTX","date":"2026-08-28","current":-1.266063,"percent":0.547244,"low":-9.235249,"twenty":-3.196476,"median":-2.253386,"eighty":-1.408152,"high":-0.963611,"avg":-2.512138,"sd":1.275667,"marketCap":78845646},"quantilePoints":[{"date":"2023-06-09","current":-9.235249,"twenty":-9.235249,"median":-9.19865,"eighty":-8.861936,"marketCap":260505032},{"date":"2023-06-16","current":-4.797096,"twenty":-9.19133,"median":-5.471097,"eighty":-5.286091,"marketCap":135315000},{"date":"2023-06-23","current":-3.669177,"twenty":-9.011993,"median":-5.35246,"eighty":-4.343178,"marketCap":103499000},{"date":"2023-06-30","current":-3.232452,"twenty":-8.711878,"median":-5.281964,"eighty":-3.931212,"marketCap":91180000},{"date":"2023-07-07","current":-3.782657,"twenty":-7.82363,"median":-4.797096,"eighty":-3.594899,"marketCap":106700000},{"date":"2023-07-14","current":-3.799851,"twenty":-5.457342,"median":-4.009616,"eighty":-3.669177,"marketCap":107185000},{"date":"2023-07-21","current":-3.868626,"twenty":-5.416077,"median":-3.868626,"eighty":-3.616907,"marketCap":109125000},{"date":"2023-07-28","current":-3.026831,"twenty":-5.342487,"median":-3.782657,"eighty":-3.314983,"marketCap":85379914},{"date":"2023-08-04","current":-2.958445,"twenty":-5.286091,"median":-3.758585,"eighty":-2.99472,"marketCap":83450898},{"date":"2023-08-11","current":-2.973312,"twenty":-5.075638,"median":-3.643386,"eighty":-2.969744,"marketCap":83870250},{"date":"2023-08-18","current":-2.842099,"twenty":-4.570137,"median":-3.57633,"eighty":-2.953093,"marketCap":83656289},{"date":"2023-08-25","current":-2.726636,"twenty":-4.18018,"median":-3.222136,"eighty":-2.868421,"marketCap":79553028},{"date":"2023-09-01","current":-2.370739,"twenty":-4.067388,"median":-3.000071,"eighty":-2.849368,"marketCap":69169264},{"date":"2023-09-07","current":-2.433882,"twenty":-3.951844,"median":-2.973312,"eighty":-2.844375,"marketCap":71011545},{"date":"2023-09-15","current":-2.413791,"twenty":-3.886508,"median":-2.973312,"eighty":-2.761879,"marketCap":70425365},{"date":"2023-09-22","current":-2.293245,"twenty":-3.841116,"median":-2.967365,"eighty":-2.647421,"marketCap":66908283},{"date":"2023-09-29","current":-2.413791,"twenty":-3.792973,"median":-2.953985,"eighty":-2.537207,"marketCap":70425365},{"date":"2023-10-04","current":-2.276024,"twenty":-3.782657,"median":-2.940605,"eighty":-2.474064,"marketCap":66405843},{"date":"2023-10-10","current":-2.098075,"twenty":-3.781281,"median":-2.875192,"eighty":-2.428715,"marketCap":61213961},{"date":"2023-10-19","current":-2.009101,"twenty":-3.779218,"median":-2.868708,"eighty":-2.413791,"marketCap":58618021},{"date":"2023-10-27","current":-1.922996,"twenty":-3.775091,"median":-2.867273,"eighty":-2.413791,"marketCap":56105820},{"date":"2023-11-03","current":-1.871334,"twenty":-3.740703,"median":-2.849368,"eighty":-2.290949,"marketCap":54598499},{"date":"2023-11-10","current":-1.690515,"twenty":-3.669177,"median":-2.844944,"eighty":-2.243878,"marketCap":49322877},{"date":"2023-11-17","current":-1.533738,"twenty":-3.658861,"median":-2.768921,"eighty":-2.084298,"marketCap":50453368},{"date":"2023-11-24","current":-1.527374,"twenty":-3.617595,"median":-2.739552,"eighty":-1.974659,"marketCap":50244018},{"date":"2023-12-01","current":-1.565558,"twenty":-3.614157,"median":-2.617571,"eighty":-1.90147,"marketCap":51500118},{"date":"2023-12-08","current":-1.48919,"twenty":-3.583895,"median":-2.583129,"eighty":-1.87076,"marketCap":48987917},{"date":"2023-12-15","current":-1.540102,"twenty":-3.452534,"median":-2.531467,"eighty":-1.708711,"marketCap":50662718},{"date":"2023-12-22","current":-1.476462,"twenty":-3.314983,"median":-2.474064,"eighty":-1.60527,"marketCap":48569217},{"date":"2023-12-29","current":-2.102685,"twenty":-3.232452,"median":-2.429577,"eighty":-1.641927,"marketCap":69169264},{"date":"2024-01-05","current":-2.03949,"twenty":-3.220072,"median":-2.413791,"eighty":-1.611379,"marketCap":67090423},{"date":"2024-01-12","current":-1.576818,"twenty":-3.100826,"median":-2.392265,"eighty":-1.585578,"marketCap":51870515},{"date":"2024-01-19","current":-1.427896,"twenty":-3.005423,"median":-2.30616,"eighty":-1.564031,"marketCap":46971633},{"date":"2024-01-26","current":-1.124213,"twenty":-2.973312,"median":-2.283466,"eighty":-1.540772,"marketCap":36981756},{"date":"2024-02-02","current":-1.314015,"twenty":-2.973312,"median":-2.260238,"eighty":-1.528392,"marketCap":43225429},{"date":"2024-02-09","current":-1.226414,"twenty":-2.973312,"median":-2.227231,"eighty":-1.508027,"marketCap":40343734},{"date":"2024-02-16","current":-1.220574,"twenty":-2.970933,"median":-2.10038,"eighty":-1.496317,"marketCap":40151621},{"date":"2024-02-23","current":-1.170933,"twenty":-2.967365,"median":-2.077039,"eighty":-1.484607,"marketCap":38518660},{"date":"2024-03-01","current":-1.185534,"twenty":-2.965581,"median":-2.037802,"eighty":-1.427936,"marketCap":38998943},{"date":"2024-03-08","current":-1.305255,"twenty":-2.958445,"median":-1.951697,"eighty":-1.350807,"marketCap":42937259},{"date":"2024-03-15","current":-1.530098,"twenty":-2.956661,"median":-1.917256,"eighty":-1.360152,"marketCap":50333611},{"date":"2024-03-22","current":-1.927222,"twenty":-2.947741,"median":-1.909363,"eighty":-1.380707,"marketCap":63397296},{"date":"2024-03-28","current":-2.178345,"twenty":-2.940605,"median":-1.925109,"eighty":-1.425549,"marketCap":71658156},{"date":"2024-04-05","current":-2.18389,"twenty":-2.875192,"median":-1.928736,"eighty":-1.427896,"marketCap":76862025},{"date":"2024-04-12","current":-2.872164,"twenty":-2.872164,"median":-2.000282,"eighty":-1.428095,"marketCap":101085828},{"date":"2024-04-19","current":-2.390082,"twenty":-2.870144,"median":-2.037802,"eighty":-1.436656,"marketCap":84118945},{"date":"2024-04-26","current":-2.64274,"twenty":-2.867273,"median":-2.070475,"eighty":-1.460017,"marketCap":93011227},{"date":"2024-05-03","current":-2.613699,"twenty":-2.860548,"median":-2.080854,"eighty":-1.476462,"marketCap":91989126},{"date":"2024-05-10","current":-2.758904,"twenty":-2.852923,"median":-2.121507,"eighty":-1.483377,"marketCap":97099633},{"date":"2024-05-17","current":-2.458726,"twenty":-2.860548,"median":-2.154849,"eighty":-1.484098,"marketCap":95873111},{"date":"2024-05-24","current":-2.3198,"twenty":-2.852923,"median":-2.20556,"eighty":-1.486644,"marketCap":90455973},{"date":"2024-05-31","current":-1.968554,"twenty":-2.850079,"median":-2.181118,"eighty":-1.488681,"marketCap":76759815},{"date":"2024-06-07","current":-2.125179,"twenty":-2.849368,"median":-2.152608,"eighty":-1.489212,"marketCap":82867106},{"date":"2024-06-14","current":-2.233016,"twenty":-2.846714,"median":-2.152608,"eighty":-1.492255,"marketCap":87071996},{"date":"2024-06-21","current":-1.741174,"twenty":-2.844944,"median":-2.140329,"eighty":-1.496317,"marketCap":67893594},{"date":"2024-06-28","current":-1.812189,"twenty":-2.844944,"median":-2.140329,"eighty":-1.498354,"marketCap":70662668},{"date":"2024-07-05","current":-0.967903,"twenty":-2.843237,"median":-2.110101,"eighty":-1.488172,"marketCap":37741454},{"date":"2024-07-12","current":-1.249432,"twenty":-2.834001,"median":-2.100781,"eighty":-1.469884,"marketCap":48719089},{"date":"2024-07-15","current":-1.260464,"twenty":-2.831302,"median":-2.098877,"eighty":-1.455345,"marketCap":49149280},{"date":"2024-08-02","current":-1.401267,"twenty":-2.828603,"median":-2.098877,"eighty":-1.436656,"marketCap":54639616},{"date":"2024-08-09","current":-1.290931,"twenty":-2.802466,"median":-2.080854,"eighty":-1.401267,"marketCap":50337284},{"date":"2024-08-16","current":-1.201045,"twenty":-2.796658,"median":-2.072003,"eighty":-1.349055,"marketCap":46438413},{"date":"2024-08-23","current":-1.241178,"twenty":-2.769689,"median":-2.062918,"eighty":-1.296495,"marketCap":47990130},{"date":"2024-08-30","current":-1.113164,"twenty":-2.768153,"median":-2.038646,"eighty":-1.281895,"marketCap":43040476},{"date":"2024-09-06","current":-1.110381,"twenty":-2.760754,"median":-2.011962,"eighty":-1.261256,"marketCap":42932874},{"date":"2024-09-13","current":-1.132616,"twenty":-2.753755,"median":-1.991463,"eighty":-1.24953,"marketCap":43792608},{"date":"2024-09-20","current":-1.430415,"twenty":-2.736707,"median":-1.971607,"eighty":-1.23844,"marketCap":55307011},{"date":"2024-09-27","current":-1.355277,"twenty":-2.727862,"median":-1.927222,"eighty":-1.247781,"marketCap":52401779},{"date":"2024-10-04","current":-1.35806,"twenty":-2.717602,"median":-1.920126,"eighty":-1.24953,"marketCap":52509380},{"date":"2024-10-11","current":-1.333014,"twenty":-2.703726,"median":-1.89225,"eighty":-1.251663,"marketCap":51540970},{"date":"2024-10-18","current":-1.327448,"twenty":-2.69392,"median":-1.871334,"eighty":-1.251663,"marketCap":51325767},{"date":"2024-10-25","current":-1.330231,"twenty":-2.68748,"median":-1.868821,"eighty":-1.256738,"marketCap":51433368},{"date":"2024-10-31","current":-1.15769,"twenty":-2.682816,"median":-1.860061,"eighty":-1.249543,"marketCap":44762095},{"date":"2024-11-08","current":-1.282921,"twenty":-2.678751,"median":-1.809791,"eighty":-1.251136,"marketCap":49604148},{"date":"2024-11-15","current":-1.251898,"twenty":-2.674104,"median":-1.720841,"eighty":-1.252073,"marketCap":58642648},{"date":"2024-11-22","current":-1.176095,"twenty":-2.654356,"median":-1.667384,"eighty":-1.249488,"marketCap":55091809},{"date":"2024-11-29","current":-1.171024,"twenty":-2.64274,"median":-1.629813,"eighty":-1.227353,"marketCap":54854273},{"date":"2024-12-06","current":-1.106606,"twenty":-2.639384,"median":-1.600178,"eighty":-1.22448,"marketCap":51836749},{"date":"2024-12-13","current":-1.148018,"twenty":-2.631897,"median":-1.571188,"eighty":-1.222594,"marketCap":53776586},{"date":"2024-12-20","current":-1.167573,"twenty":-2.62396,"median":-1.563013,"eighty":-1.217317,"marketCap":54692620},{"date":"2024-12-27","current":-1.166423,"twenty":-2.616797,"median":-1.547739,"eighty":-1.213926,"marketCap":54638735},{"date":"2025-01-03","current":-1.182527,"twenty":-2.613699,"median":-1.540102,"eighty":-1.211814,"marketCap":55393116},{"date":"2025-01-10","current":-1.304461,"twenty":-2.611376,"median":-1.530098,"eighty":-1.211814,"marketCap":61104858},{"date":"2025-01-17","current":-1.48161,"twenty":-2.609328,"median":-1.528647,"eighty":-1.213041,"marketCap":69403049},{"date":"2025-01-24","current":-1.656458,"twenty":-2.608318,"median":-1.528647,"eighty":-1.213574,"marketCap":77593471},{"date":"2025-01-31","current":-2.167199,"twenty":-2.60789,"median":-1.530098,"eighty":-1.21433,"marketCap":101518124},{"date":"2025-02-07","current":-2.162598,"twenty":-2.593884,"median":-1.54094,"eighty":-1.214734,"marketCap":101302587},{"date":"2025-02-14","current":-1.769189,"twenty":-2.583696,"median":-1.557921,"eighty":-1.214981,"marketCap":82874137},{"date":"2025-02-21","current":-1.863515,"twenty":-2.577932,"median":-1.565558,"eighty":-1.217317,"marketCap":87292655},{"date":"2025-02-28","current":-1.902626,"twenty":-2.570137,"median":-1.584118,"eighty":-1.220574,"marketCap":89124723},{"date":"2025-03-07","current":-1.833607,"twenty":-2.564329,"median":-1.603098,"eighty":-1.220574,"marketCap":85891661},{"date":"2025-03-14","current":-2.672649,"twenty":-2.570137,"median":-1.649192,"eighty":-1.221023,"marketCap":125194918},{"date":"2025-03-21","current":-2.747078,"twenty":-2.60789,"median":-1.669929,"eighty":-1.222594,"marketCap":128681358},{"date":"2025-03-28","current":-2.594838,"twenty":-2.612537,"median":-1.719708,"eighty":-1.224155,"marketCap":121550002},{"date":"2025-04-04","current":-1.679468,"twenty":-2.612537,"median":-1.718575,"eighty":-1.22448,"marketCap":87161019},{"date":"2025-04-11","current":-1.557114,"twenty":-2.610061,"median":-1.684991,"eighty":-1.225254,"marketCap":80811079},{"date":"2025-04-17","current":-1.492618,"twenty":-2.608747,"median":-1.667384,"eighty":-1.226414,"marketCap":77463875},{"date":"2025-04-25","current":-1.557114,"twenty":-2.60789,"median":-1.641927,"eighty":-1.226584,"marketCap":80811079},{"date":"2025-05-02","current":-1.541757,"twenty":-2.60528,"median":-1.62119,"eighty":-1.227308,"marketCap":80014126},{"date":"2025-05-09","current":-1.710675,"twenty":-2.59278,"median":-1.624681,"eighty":-1.230226,"marketCap":88780614},{"date":"2025-05-16","current":-1.653585,"twenty":-2.584263,"median":-1.647756,"eighty":-1.242829,"marketCap":84795847},{"date":"2025-05-23","current":-1.600745,"twenty":-2.580531,"median":-1.656458,"eighty":-1.249451,"marketCap":82086205},{"date":"2025-05-30","current":-2.337537,"twenty":-2.570137,"median":-1.661535,"eighty":-1.249526,"marketCap":119868907},{"date":"2025-06-06","current":-2.328187,"twenty":-2.570137,"median":-1.667973,"eighty":-1.249555,"marketCap":119389431},{"date":"2025-06-13","current":-2.499606,"twenty":-2.555617,"median":-1.681559,"eighty":-1.251898,"marketCap":128179818},{"date":"2025-06-20","current":-2.480906,"twenty":-2.548647,"median":-1.689176,"eighty":-1.252132,"marketCap":127220867},{"date":"2025-06-27","current":-2.462206,"twenty":-2.546034,"median":-1.702427,"eighty":-1.256738,"marketCap":126261915},{"date":"2025-07-03","current":-2.465323,"twenty":-2.537207,"median":-1.714625,"eighty":-1.258423,"marketCap":126421741},{"date":"2025-07-11","current":-2.577524,"twenty":-2.561425,"median":-1.730079,"eighty":-1.259794,"marketCap":132175448},{"date":"2025-07-18","current":-2.898546,"twenty":-2.579766,"median":-1.757979,"eighty":-1.261058,"marketCap":148637445},{"date":"2025-07-25","current":-3.057499,"twenty":-2.600059,"median":-1.764061,"eighty":-1.263206,"marketCap":156788531},{"date":"2025-08-01","current":-3.057499,"twenty":-2.611957,"median":-1.792196,"eighty":-1.270493,"marketCap":156788531},{"date":"2025-08-08","current":-2.826862,"twenty":-2.625853,"median":-1.812189,"eighty":-1.274572,"marketCap":144961465},{"date":"2025-08-15","current":-2.971121,"twenty":-2.638357,"median":-1.82441,"eighty":-1.276242,"marketCap":162258860},{"date":"2025-08-22","current":-3.41649,"twenty":-2.660123,"median":-1.836892,"eighty":-1.279025,"marketCap":186581365},{"date":"2025-08-29","current":-3.090683,"twenty":-2.678751,"median":-1.856037,"eighty":-1.280138,"marketCap":168788391},{"date":"2025-09-05","current":-3.243125,"twenty":-2.691143,"median":-1.861215,"eighty":-1.280841,"marketCap":177113544},{"date":"2025-09-12","current":-3.461326,"twenty":-2.704217,"median":-1.868463,"eighty":-1.282305,"marketCap":189029939},{"date":"2025-09-19","current":-3.426952,"twenty":-2.741354,"median":-1.870693,"eighty":-1.282921,"marketCap":187152699},{"date":"2025-09-26","current":-3.243125,"twenty":-2.769075,"median":-1.877319,"eighty":-1.282921,"marketCap":177113544},{"date":"2025-10-03","current":-3.308884,"twenty":-2.807845,"median":-1.880771,"eighty":-1.283679,"marketCap":180704787},{"date":"2025-10-10","current":-3.302906,"twenty":-2.827907,"median":-1.893424,"eighty":-1.284815,"marketCap":180378310},{"date":"2025-10-17","current":-3.004001,"twenty":-2.847185,"median":-1.902048,"eighty":-1.285226,"marketCap":164054481},{"date":"2025-10-24","current":-2.839603,"twenty":-2.847185,"median":-1.911829,"eighty":-1.285928,"marketCap":155076375},{"date":"2025-10-31","current":-2.764876,"twenty":-2.849368,"median":-1.920126,"eighty":-1.286056,"marketCap":150995418},{"date":"2025-11-07","current":-2.711073,"twenty":-2.849092,"median":-1.927222,"eighty":-1.288006,"marketCap":148057129},{"date":"2025-11-14","current":-2.723029,"twenty":-2.847185,"median":-1.960142,"eighty":-1.291742,"marketCap":148710082},{"date":"2025-11-21","current":-3.044807,"twenty":-2.852183,"median":-1.968554,"eighty":-1.293396,"marketCap":139625737},{"date":"2025-11-28","current":-3.566883,"twenty":-2.866671,"median":-1.979039,"eighty":-1.294541,"marketCap":163566570},{"date":"2025-12-05","current":-3.172468,"twenty":-2.874818,"median":-2.003244,"eighty":-1.298088,"marketCap":145479882},{"date":"2025-12-12","current":-3.189617,"twenty":-2.895724,"median":-2.026861,"eighty":-1.30462,"marketCap":146266260},{"date":"2025-12-19","current":-3.044807,"twenty":-2.909766,"median":-2.045829,"eighty":-1.306911,"marketCap":139625737},{"date":"2025-12-26","current":-3.121023,"twenty":-2.940605,"median":-2.061171,"eighty":-1.313533,"marketCap":143120749},{"date":"2026-01-02","current":-3.033375,"twenty":-2.951309,"median":-2.069254,"eighty":-1.313919,"marketCap":139101485},{"date":"2026-01-09","current":-3.140077,"twenty":-2.967365,"median":-2.073224,"eighty":-1.319745,"marketCap":143994502},{"date":"2026-01-16","current":-2.976214,"twenty":-2.971559,"median":-2.091032,"eighty":-1.321741,"marketCap":136480226},{"date":"2026-01-23","current":-3.052429,"twenty":-2.973312,"median":-2.098877,"eighty":-1.323552,"marketCap":139975238},{"date":"2026-01-30","current":-3.079104,"twenty":-2.996791,"median":-2.104138,"eighty":-1.326335,"marketCap":141198492},{"date":"2026-02-06","current":-2.899998,"twenty":-3.001047,"median":-2.123183,"eighty":-1.329118,"marketCap":132985214},{"date":"2026-02-13","current":-3.20486,"twenty":-3.016702,"median":-2.141892,"eighty":-1.330231,"marketCap":146965263},{"date":"2026-02-20","current":-3.376345,"twenty":-3.028471,"median":-2.152608,"eighty":-1.330231,"marketCap":154829040},{"date":"2026-02-27","current":-4.473847,"twenty":-3.047094,"median":-2.164899,"eighty":-1.331344,"marketCap":205157216},{"date":"2026-03-06","current":-4.504333,"twenty":-3.057499,"median":-2.178345,"eighty":-1.333556,"marketCap":206555221},{"date":"2026-03-13","current":-4.153742,"twenty":-3.067672,"median":-2.211139,"eighty":-1.339393,"marketCap":190478164},{"date":"2026-03-20","current":-5.569355,"twenty":-3.075294,"median":-2.233016,"eighty":-1.347426,"marketCap":220384966},{"date":"2026-03-27","current":-5.030086,"twenty":-3.082722,"median":-2.237299,"eighty":-1.348526,"marketCap":199045520},{"date":"2026-04-02","current":-4.955704,"twenty":-3.086726,"median":-2.253224,"eighty":-1.350299,"marketCap":196102148},{"date":"2026-04-10","current":-4.783695,"twenty":-3.093606,"median":-2.276024,"eighty":-1.355785,"marketCap":189295601},{"date":"2026-04-17","current":-5.857586,"twenty":-3.105152,"median":-2.29181,"eighty":-1.357865,"marketCap":231790532},{"date":"2026-04-24","current":-5.50892,"twenty":-3.121023,"median":-2.3198,"eighty":-1.360347,"marketCap":217993476},{"date":"2026-05-01","current":-4.937108,"twenty":-3.143126,"median":-2.325304,"eighty":-1.369992,"marketCap":195366305},{"date":"2026-05-08","current":-4.653527,"twenty":-3.147846,"median":-2.361395,"eighty":-1.372531,"marketCap":184144700},{"date":"2026-05-15","current":-4.989852,"twenty":-3.167307,"median":-2.38041,"eighty":-1.376983,"marketCap":200517206},{"date":"2026-05-22","current":-4.532067,"twenty":-3.181169,"median":-2.40143,"eighty":-1.386168,"marketCap":182121132},{"date":"2026-05-29","current":-4.857095,"twenty":-3.20486,"median":-2.406105,"eighty":-1.387284,"marketCap":195182345},{"date":"2026-06-05","current":-6.376939,"twenty":-3.220103,"median":-2.413791,"eighty":-1.391455,"marketCap":256257310},{"date":"2026-06-12","current":-6.381517,"twenty":-3.240136,"median":-2.425271,"eighty":-1.394238,"marketCap":256441271},{"date":"2026-06-18","current":-2.156165,"twenty":-3.240734,"median":-2.415455,"eighty":-1.393681,"marketCap":86645508},{"date":"2026-06-26","current":-1.779734,"twenty":-3.235354,"median":-2.413791,"eighty":-1.395448,"marketCap":71518597},{"date":"2026-07-02","current":-2.439422,"twenty":-3.233134,"median":-2.409948,"eighty":-1.396192,"marketCap":98028157},{"date":"2026-07-10","current":-1.656339,"twenty":-3.228095,"median":-2.40143,"eighty":-1.396192,"marketCap":66559974},{"date":"2026-07-17","current":-1.518706,"twenty":-3.222138,"median":-2.38041,"eighty":-1.398476,"marketCap":61029203},{"date":"2026-07-24","current":-1.838338,"twenty":-3.220103,"median":-2.361395,"eighty":-1.400681,"marketCap":73873607},{"date":"2026-07-31","current":-1.698274,"twenty":-3.217817,"median":-2.328187,"eighty":-1.401795,"marketCap":68245142},{"date":"2026-08-07","current":-1.832502,"twenty":-3.21336,"median":-2.321111,"eighty":-1.403699,"marketCap":73639088},{"date":"2026-08-14","current":-2.06017,"twenty":-3.209035,"median":-2.293245,"eighty":-1.405369,"marketCap":82787928},{"date":"2026-08-21","current":-2.135694,"twenty":-3.203336,"median":-2.279745,"eighty":-1.406482,"marketCap":80816787},{"date":"2026-08-28","current":-2.083604,"twenty":-3.196476,"median":-2.253386,"eighty":-1.408152,"marketCap":78845646}],"updateTime":1788188251496},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ELTX\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2648577672","title":"Elicio Therapeutics Prices $15 Million Direct Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2648577672","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648577672?lang=en_us&edition=fundamental","pubTime":"2026-07-02 15:39","pubTimestamp":1782977961,"startTime":"0","endTime":"0","summary":"Elicio Therapeutics  has priced a registered direct offering of about 4.4 million common shares for gross proceeds of about $15 million, the company said Thursday.The offering, led by two new fundamental institutional investors and an existing shareholder, is expected to close on or about July 6, Elicio said.Net proceeds will be used to primarily fund the planned phase 1 clinical development of ELI-002 7P, as well as its pipeline and platform, working capital, and general corporate purposes, the company said.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","BK4007","ELTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648576088","title":"Elicio Therapeutics Announces Pricing of $15 Million Registered Direct Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2648576088","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648576088?lang=en_us&edition=fundamental","pubTime":"2026-07-02 12:25","pubTimestamp":1782966309,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260702:nTUA4HSKMX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","ELTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647792373","title":"Elicio Therapeutics Added to Russell 2000® and Russell 3000® Indexes","url":"https://stock-news.laohu8.com/highlight/detail?id=2647792373","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647792373?lang=en_us&edition=fundamental","pubTime":"2026-06-29 20:00","pubTimestamp":1782734400,"startTime":"0","endTime":"0","summary":"BOSTON, June  29, 2026  (GLOBE NEWSWIRE) -- Elicio Therapeutics, Inc. (Nasdaq: ELTX) (“Elicio” or the “Company”), a clinical-stage biotechnology company developing next-generation immunotherapies for ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/06/29/3318881/0/en/Elicio-Therapeutics-Added-to-Russell-2000-and-Russell-3000-Indexes.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ELTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646706278","title":"Elicio Therapeutics Posts Amplify-7p Presentation on Eli-002 7P in Metastatic Mkras Pancreatic Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2646706278","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646706278?lang=en_us&edition=fundamental","pubTime":"2026-06-25 20:06","pubTimestamp":1782389188,"startTime":"0","endTime":"0","summary":"Elicio Therapeutics posts AMPLIFY-7P presentation on ELI-002 7P in metastatic mKRAS pancreatic cancerElicio Therapeutics published an AMPLIFY-7P research presentation outlining a development path for ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260625:nNDL3L6Fz4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4007","ELTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646846919","title":"Analysts Conflicted on These Healthcare Names: Phathom Pharmaceuticals (PHAT) and Elicio Therapeutics (ELTX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2646846919","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646846919?lang=en_us&edition=fundamental","pubTime":"2026-06-25 04:40","pubTimestamp":1782333620,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Phathom Pharmaceuticals (PHAT) and Elicio Therapeutics (ELTX). Ph...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-phathom-pharmaceuticals-phat-and-elicio-therapeutics-eltx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-phathom-pharmaceuticals-phat-and-elicio-therapeutics-eltx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PHAT","ELTX","BK4588","LABU","LU0029874061.USD","LU0128526141.USD","BK4139","BK4007","XLV","BK4137","BK4581","BK4585","XBI","HCSG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645026491","title":"Analysts Have Conflicting Sentiments on These Healthcare Companies: Damora Therapeutics (DMRA), Summit Therapeutics (SMMT) and Elicio Therapeutics (ELTX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2645026491","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645026491?lang=en_us&edition=fundamental","pubTime":"2026-06-22 18:33","pubTimestamp":1782124427,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Damora Therapeutics (DMRA), Summit Therapeutics (S...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-damora-therapeutics-dmra-summit-therapeutics-smmt-and-elicio-therapeutics-eltx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-damora-therapeutics-dmra-summit-therapeutics-smmt-and-elicio-therapeutics-eltx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","ELTX","SMMT","BK4139","DMRA","BK4581","XLV","HCSG","LU0128526141.USD","LU0029874061.USD","LU2488822045.USD","BK4585","BK4007","BK4137","LABU","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644033710","title":"Elicio Therapeutics Coverage Assumed by Ladenburg Thalmann at Buy","url":"https://stock-news.laohu8.com/highlight/detail?id=2644033710","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644033710?lang=en_us&edition=fundamental","pubTime":"2026-06-19 03:13","pubTimestamp":1781809980,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ELTX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  June 18, 2026 15:13 ET (19:13 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4007","ELTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644086716","title":"Elicio Therapeutics assumed with a Buy at Ladenburg","url":"https://stock-news.laohu8.com/highlight/detail?id=2644086716","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644086716?lang=en_us&edition=fundamental","pubTime":"2026-06-18 21:15","pubTimestamp":1781788522,"startTime":"0","endTime":"0","summary":"Ladenburg assumed coverage of Elicio Therapeutics (ELTX) with a Buy rating and $12 price target The firm views the selloff post the Phase II ELI-00...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/elicio-therapeutics-assumed-with-a-buy-at-ladenburg-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/elicio-therapeutics-assumed-with-a-buy-at-ladenburg-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","ELTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644669088","title":"Top Premarket Decliners","url":"https://stock-news.laohu8.com/highlight/detail?id=2644669088","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644669088?lang=en_us&edition=fundamental","pubTime":"2026-06-18 19:34","pubTimestamp":1781782477,"startTime":"0","endTime":"0","summary":"INLIF  shares were down 43% in Thursday premarket activity, extending the previous session's 88% decline.Sleep Number  stock was down 40% after the company said in a regulatory filing that it received a Nasdaq delisting notice related to its Chapter 11 filing and associated public interest and compliance concerns.NovoCure  shares were down 21% after a phase 3 trial evaluating its Tumor Treating Fields therapy in patients with newly diagnosed glioblastoma failed to meet its primary endpoint.Elicio Therapeutics  stock was down 20%, following Wednesday's 70% gain.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ELTX","SNBRQ","INLF","BK4139","BK4548","BK4082","BK4007","BK4161","BK4534","BK4588","SNBR","NVCR","BK4585","BK4178"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644374414","title":"Elicio Reports Complete Responses in 3 Pancreatic Cancer Patients After ELI-002 7P, Nivolumab Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2644374414","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644374414?lang=en_us&edition=fundamental","pubTime":"2026-06-17 22:20","pubTimestamp":1781706041,"startTime":"0","endTime":"0","summary":"Elicio Therapeutics  said Wednesday that three patients who received ELI-002 7P in the phase 2 Amplify-7P study and later experienced disease progression subsequently achieved complete radiographic and complete metabolic responses after receiving nivolumab-based therapy.The company said it intends to continue monitoring additional patients who participated in the Amplify-7P study and are currently following a similar course of treatment.Elicio said the findings support further evaluation of checkpoint inhibitor combinations and could help inform future development strategies in metastatic pancreatic ductal adenocarcinoma and the design of a planned phase 3 trial in adjuvant PDAC.Subject to funding, the company also plans to initiate a phase 1 study evaluating ELI-002 7P in combination with gemcitabine/nab-paclitaxel chemotherapy and an anti-PD-1 inhibitor in treatment-naive metastatic mKRAS pancreatic cancer.Price: 3.16, Change: +0.40, Percent Change: +14.49","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","ELTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644419887","title":"Elicio Therapeutics reports complete responses in pancreatic cancer trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2644419887","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644419887?lang=en_us&edition=fundamental","pubTime":"2026-06-17 21:28","pubTimestamp":1781702934,"startTime":"0","endTime":"0","summary":"Elicio Therapeutics (ELTX) reported preliminary clinical observations from its recently completed Phase 2 AMPLIFY-7P study of its cancer immunother...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/elicio-therapeutics-reports-complete-responses-in-pancreatic-cancer-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/elicio-therapeutics-reports-complete-responses-in-pancreatic-cancer-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ELTX","BK4139","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644745670","title":"Elicio Therapeutics plans Phase 1 trial of ELI-002 7P plus anti-PD-1, chemo in metastatic mKRAS pancreatic cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2644745670","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644745670?lang=en_us&edition=fundamental","pubTime":"2026-06-17 20:03","pubTimestamp":1781697789,"startTime":"0","endTime":"0","summary":"Elicio Therapeutics reported preliminary Phase 2 AMPLIFY-7P observations that support testing ELI-002 7P with checkpoint inhibitors in metastatic mKRAS pancreatic cancer.Results have not been presented yet; a virtual key opinion leader event is scheduled for June 24, 2026.Three patients later achieved confirmed complete tumor responses on nivolumab-based therapy, suggesting ELI-002 7P may prime sensitivity to immunotherapy.The company plans a funding-dependent Phase 1 trial in first-line metastatic mKRAS PDAC combining ELI-002 7P, standard chemotherapy, and an anti-PD-1 drug.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260617:nNDLgS6Pq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014039.USD","SG9999014021.USD","BK4588","LU2095319765.USD","LU2210150020.SGD","IE00BN0W2W23.USD","IE00BKPKM429.USD","NDAQ","SG9999014013.SGD","IE00BGHQF748.EUR","IE00BN0W2T93.GBP","LU0314104364.USD","IE00B3QW5Z07.USD","SG9999014005.SGD","BK4112","BK4139","BK4007","IE00BN0W2V16.EUR","LU2210149790.SGD","ELTX","IE00B64PRP62.GBP","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644745653","title":"Elicio Therapeutics - Complete Responses Observed in Mss/Mmr-P Patients With Historically Checkpoint Inhibitor Response","url":"https://stock-news.laohu8.com/highlight/detail?id=2644745653","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644745653?lang=en_us&edition=fundamental","pubTime":"2026-06-17 20:00","pubTimestamp":1781697605,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260617:nTUA3JN5DY:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ELTX","BK4007","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644745632","title":"Elicio Therapeutics - Reports 100% Confirmed Complete Responses in Three Patients After Eli-2 7P and Nivolumab","url":"https://stock-news.laohu8.com/highlight/detail?id=2644745632","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644745632?lang=en_us&edition=fundamental","pubTime":"2026-06-17 20:00","pubTimestamp":1781697605,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260617:nTUA3JN5DY:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4007","ELTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644456557","title":"Elicio Therapeutics - Two Patients Maintain Complete Responses for at Least Eight Months, One Over 13 Months","url":"https://stock-news.laohu8.com/highlight/detail?id=2644456557","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644456557?lang=en_us&edition=fundamental","pubTime":"2026-06-17 20:00","pubTimestamp":1781697605,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260617:nTUA3JN5DY:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ELTX","BK4139","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644456307","title":"Elicio Therapeutics - Plans to Initiate Phase 1 Study in Metastatic Pancreatic Ductal Adenocarcinoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2644456307","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644456307?lang=en_us&edition=fundamental","pubTime":"2026-06-17 20:00","pubTimestamp":1781697605,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260617:nTUA3JN5DY:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ELTX","BK4139","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644455297","title":"Elicio Therapeutics Reports Multiple Complete Responses After Eli-002 7P Treatment and Subsequent Therapy With Checkpoint Inhibition in Metastatic Mkras Pancreatic Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2644455297","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644455297?lang=en_us&edition=fundamental","pubTime":"2026-06-17 20:00","pubTimestamp":1781697605,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260617:nTUA3JN5DY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ELTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644276007","title":"SueWallSt opens probe into Elicio Therapeutics officers, directors after 72.53% stock plunge","url":"https://stock-news.laohu8.com/highlight/detail?id=2644276007","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644276007?lang=en_us&edition=fundamental","pubTime":"2026-06-17 04:44","pubTimestamp":1781642662,"startTime":"0","endTime":"0","summary":"SueWallSt opened a securities investigation into Elicio Therapeutics tied to disclosures on its ELI-002 7P pancreatic cancer program.Shares fell 72.53% in one session following release of Phase 2 AMPLIFY-7P results that missed the primary disease-free survival endpoint.The probe focuses on whether prior statements on ELI-002 7P prospects or the AMPLIFY-7P program were materially misleading.The alert cited a June 9 Q1 2026 filing showing zero revenue and a widening net loss driven by higher R&D spending.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260616:nNDL4Pybgy:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ELTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644769122","title":"Elicio Therapeutics Cut to Hold From Buy by Jones Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2644769122","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644769122?lang=en_us&edition=fundamental","pubTime":"2026-06-17 00:38","pubTimestamp":1781627880,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ELTX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  June 16, 2026 12:38 ET (16:38 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4007","ELTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643120785","title":"Elicio Therapeutics downgraded to Hold from Buy at JonesResearch","url":"https://stock-news.laohu8.com/highlight/detail?id=2643120785","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643120785?lang=en_us&edition=fundamental","pubTime":"2026-06-16 04:11","pubTimestamp":1781554298,"startTime":"0","endTime":"0","summary":"JonesResearch downgraded Elicio Therapeutics (ELTX) to Hold from Buy without a price target The company’s Phase IIb trial failed to show a signific...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/elicio-therapeutics-downgraded-to-hold-from-buy-at-jonesresearch-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/elicio-therapeutics-downgraded-to-hold-from-buy-at-jonesresearch-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ELTX"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":2,"totalSize":87,"code":"91000000","status":"200"}]}}